Speakers

Agustina Rodriguez-Granillo

Principal Scientist II

Schrodinger

Alessio Ciulli

Professor of Structural Chemical Biology

University of Dundee

Benedict Cross

Senior Director of Technology

PhoreMost

Bomie Han

Research Advisor

Eli Lilly

Brian Jones

Chief Scientific Officer

Cedilla Therapeutics

Danette Daniels

Group Leader of Functional Proteomics

Promega

David Rubinsztein

Professor of Molecular Neurogenetics & UK Dementia Research Institute

University of Cambridge

Davide Gianni

Associate Director of Genomics

AstraZeneca

Georg Winter

Principal Investigator

CeMM Research Centre for Molecular Medicine

Gopal Sapkota

Principal Investigator

University of Dundee

Ivan Dikic

Director of Institute of Biochemistry II

Goethe University Frankfurt

Jin Li

Chairman & Chief Executive Officer

HitGen

John Harling

Senior Scientific Director of Medicinal Chemistry

GlaxoSmithKline

Laura Luh

Research Scientist

Bayer AG

Paul Thompson

Vice President of Clinical Development

Mission Therapeutics

Simon Bailey

Executive Vice President & Head of Drug Discovery

Plexium

Terry Rabbitts

Professor of Molecular Immunology

Weatherall Institute of Molecular Medicine; University of Oxford; The Institute of Cancer Research

Tom Coulter

Director of Integrated Drug Discovery

Selvita